| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.001 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.001 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.002 |